Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03581838 · ClinicalTrials.gov registry record
Eating With Eosinophilic Esophagitis (EoE)
A clinical trial of Eosinophilic Esophagitis (EoE), sponsored by Mayo Clinic.
- Completed
- Registry status
- 31
- Enrollment target
- 1
- Study location
NCT03581838: Completed study of Eosinophilic Esophagitis (EoE), sponsored by Mayo Clinic.
NCT03581838 is a study of Eosinophilic Esophagitis (EoE) that has completed, run by Mayo Clinic. The registered enrollment target is 31 participants, below the 123-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03581838, a study of Eosinophilic Esophagitis (EoE), has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
Is there a difference in the eating process for patients with active Eosinophilic Esophagitis (EoE) and those with inactive disease?
Primary Outcome
number of bites of patient's with EoE and controls eating a Jimmy John's sandwich
Conditions Studied
Interventions
- BEHAVIORAL Observed eating session
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-05-24 |
| Est. Completion | 2019-07-23 |
What the finished NCT03581838 record still lists
NCT03581838 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 123-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Eosinophilic Esophagitis (EoE) appearing as the primary indexed condition, and to 1 intervention - of which Observed eating session is the first listed.
NCT03581838 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03581838 about?
NCT03581838 is a clinical study titled "Eating With Eosinophilic Esophagitis (EoE)". Is there a difference in the eating process for patients with active Eosinophilic Esophagitis (EoE) and those with inactive disease?
What is the current status of trial NCT03581838?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2018-05-24. Estimated completion is 2019-07-23.
What conditions does trial NCT03581838 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis (EoE).
What interventions are being tested in trial NCT03581838?
The interventions under investigation include: Observed eating session (BEHAVIORAL).
Who is sponsoring clinical trial NCT03581838?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03581838 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis (EoE)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03581838's enrollment target sits among peer trials
31 8th of 10 higher than 3 of 10 other Eosinophilic Esophagitis (EoE) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis (EoE) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surface EMG Testing on Swallowing in EoE Patients
RECRUITING
-
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
RECRUITING
-
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
RECRUITING · Phase 4
-
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
RECRUITING · Phase 3
-
Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
RECRUITING
-
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI